BeiGene, Ltd.
ONC
$250.19
$5.292.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 61.44% | 55.81% | 68.47% | 74.48% | 70.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 61.44% | 55.81% | 68.47% | 74.48% | 70.41% |
| Cost of Revenue | 62.92% | 163.56% | 204.09% | 578.92% | 30.20% |
| Gross Profit | 61.17% | -6.86% | 15.16% | 39.94% | 80.62% |
| SG&A Expenses | 26.66% | 24.35% | 18.29% | 20.31% | 15.77% |
| Depreciation & Amortization | -- | -- | -150.37% | -125.31% | -100.37% |
| Other Operating Expenses | -95.09% | 207.62% | -- | -- | -- |
| Total Operating Expenses | 24.52% | 23.90% | 14.87% | 15.80% | 12.24% |
| Operating Income | 50.58% | 29.94% | 45.89% | 37.38% | 33.76% |
| Income Before Tax | 32.20% | 12.65% | 73.03% | 61.82% | 58.69% |
| Income Tax Expenses | 106.10% | -3.02% | 13.09% | 26.60% | 28.13% |
| Earnings from Continuing Operations | 23.43% | 12.11% | 70.75% | 59.96% | 56.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.43% | 12.11% | 70.75% | 59.96% | 56.84% |
| EBIT | 50.58% | 29.94% | 45.89% | 37.38% | 33.76% |
| EBITDA | 57.06% | 33.19% | 49.27% | 40.24% | 36.21% |
| EPS Basic | 24.03% | 12.47% | 70.73% | 60.21% | 57.24% |
| Normalized Basic EPS | 54.00% | -27.45% | 52.02% | 43.03% | 40.30% |
| EPS Diluted | 24.03% | 13.04% | 70.84% | 60.35% | 57.38% |
| Normalized Diluted EPS | 54.00% | -27.45% | 52.02% | 43.03% | 40.30% |
| Average Basic Shares Outstanding | 0.50% | 0.06% | 0.53% | 0.96% | 1.35% |
| Average Diluted Shares Outstanding | 0.50% | 0.06% | 0.53% | 0.96% | 1.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.22% | -0.06% | -- | -- | -- |